AR093922A1 - Composicion farmaceutica que contiene telmisartan - Google Patents

Composicion farmaceutica que contiene telmisartan

Info

Publication number
AR093922A1
AR093922A1 ARP130104632A ARP130104632A AR093922A1 AR 093922 A1 AR093922 A1 AR 093922A1 AR P130104632 A ARP130104632 A AR P130104632A AR P130104632 A ARP130104632 A AR P130104632A AR 093922 A1 AR093922 A1 AR 093922A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
telmisartan
composition containing
solution
isomalt
Prior art date
Application number
ARP130104632A
Other languages
English (en)
Original Assignee
Egis Pharmaceuticals Public Ltd Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals Public Ltd Company filed Critical Egis Pharmaceuticals Public Ltd Company
Publication of AR093922A1 publication Critical patent/AR093922A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica que comprende telmisartán como ingrediente activo, un alcalinizante, un aglutinante, un lubricante e isomalt. También, un proceso para la preparación de las composiciones farmacéuticas anteriores que comprende disolver el telmisartán en la solución acuosa de alcalinizantes, añadir en forma posterior la solución de aglutinante, pulverizar la solución que se obtuvo de ese modo sobre el isomalt en un aparato de fluidización, homogenizar el granulado que se obtuvo de ese modo con el lubricante y comprimir el producto homogenizado obtenido en comprimidos. En el proceso no se utiliza ni un agente tensioactivo, ni un emulsionante ni un desintegrante.
ARP130104632A 2012-12-11 2013-12-11 Composicion farmaceutica que contiene telmisartan AR093922A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUP1200722 2012-12-11

Publications (1)

Publication Number Publication Date
AR093922A1 true AR093922A1 (es) 2015-06-24

Family

ID=89665947

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104632A AR093922A1 (es) 2012-12-11 2013-12-11 Composicion farmaceutica que contiene telmisartan

Country Status (2)

Country Link
AR (1) AR093922A1 (es)
WO (1) WO2014091263A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
CN112870174A (zh) * 2021-02-08 2021-06-01 天方药业有限公司 一种替米沙坦片剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
CN104958273B (zh) * 2009-05-27 2017-10-13 株式会社茶山医化 含有泡腾层的多层片
EP2632438A1 (en) * 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine

Also Published As

Publication number Publication date
WO2014091263A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
UY36665A (es) Derivados de ciclohexano sustituidos con amidas
NZ631100A (en) Soft chewable pharmaceutical products
MX2021010359A (es) Una composicion farmaceutica para reducir la grasa localizada y sus usos.
CL2014003509A1 (es) Composición veterinaria masticable blanda que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal (div. sol. n°2087-14).
BR112012023324B8 (pt) processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida
CL2015003072A1 (es) Formulaciones de liberación prolongada de colchicina y métodos de uso de las mismas.
CL2015000893A1 (es) Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.
AR104212A1 (es) Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas
CL2019001447A1 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos.
AR103803A1 (es) Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
MX2016004116A (es) Formulaciones de espuma y aparatos para su suministro.
PE20151759A1 (es) Imidazopiridazinas sustituidas
DOP2017000307A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma.
DOP2016000007A (es) Pirazolpiridinas sustituidas
MX2017000041A (es) Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos.
MD4563B1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
AR080736A1 (es) Composicion farmaceutica de disolucion rapida, usualmente bucodispersable, y proceso para prepararla
MX2016012319A (es) Formulaciones antihelminticas veterinarias estables.
CL2015001748A1 (es) Formulaciones antiparasitarias transdermicas
AR055953A1 (es) Formulaciones de acido hidroxamico suberoilanilida y procedimientos para la producion de las mismas
CO2019003761A2 (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos
AR093922A1 (es) Composicion farmaceutica que contiene telmisartan
CL2016000183A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
CO6390100A2 (es) Composiciones con liberación rápida de fármaco

Legal Events

Date Code Title Description
FB Suspension of granting procedure